[1]Patent:US2008/249316,2008,A1,.Locationinpatent:Page/Pagecolumn6
[1]CurrentPatentAssignee:VTVTHERAPEUTICSINC.-US2008/249316,2008,A1Locationinpatent:Page/Pagecolumn6
[1]CurrentPatentAssignee:CRYSTALPHARMATECHCO.,LTD.;VTVTHERAPEUTICSINC.-WO2019/190823,2019,A1Locationinpatent:Page/Pagecolumn79-80
[1]CurrentPatentAssignee:CRYSTALPHARMATECHCO.,LTD.;VTVTHERAPEUTICSINC.-WO2019/190823,2019,A1Locationinpatent:Page/Pagecolumn79-80
[1]CurrentPatentAssignee:CRYSTALPHARMATECHCO.,LTD.;VTVTHERAPEUTICSINC.-WO2019/190823,2019,A1Locationinpatent:Page/Pagecolumn76
[1]CurrentPatentAssignee:CRYSTALPHARMATECHCO.,LTD.;VTVTHERAPEUTICSINC.-WO2019/190823,2019,A1Locationinpatent:Page/Pagecolumn76
Title: Effect of TTP488 in patients with mild to moderate Alzheimer's disease.
Journal: BMC neurology 20140101
Title: New therapeutic approaches for Alzheimer's disease and cerebral amyloid angiopathy.
Journal: Frontiers in aging neuroscience 20140101
Title: RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain.
Journal: Nature medicine 20030701